Publications

Latest publications

  • octobre 3, 2022

    New oral protease-activated receptor 4 antagonist BMS-986120: tolerability, pharmacokinetics, pharmacodynamics, and gene variant effects in humans.

    Merali S, Wang Z, Frost C, Callejo M, Hedrick M, Hui L, Meadows Shropshire S, Xu K, Bouvier M, DeSouza MM, Yang J
    Platelets 2022-10-03 ;33( 7 ):969-978.

  • septembre 13, 2022

    Unified gene expression signature of novel NPM1 exon 5 mutations in acute myeloid leukemia.

    Lisi V, Blanchard E, Vladovsky M, Audemard E, Ferghaly A, Lemieux S, Hébert J, Sauvageau G, Lavallée VP
    Blood Adv 2022-09-13 ;6( 17 ):5160-5164.

  • septembre 6, 2022

    3D chromatin remodeling potentiates transcriptional programs driving cell invasion.

    Lebeau B, Jangal M, Zhao T, Wong CK, Wong N, Cañedo EC, Hébert S, Aguilar-Mahecha A, Chabot C, Buchanan M, Catterall R, McCaffrey L, Deblois G, Kleinman C, Park M, Basik M, Witcher M
    Proc Natl Acad Sci U S A 2022-09-06 ;119( 36 ):e2203452119.

  • septembre 6, 2022

    Proteogenomics and Differential Ion Mobility Enable the Exploration of the Mutational Landscape in Colon Cancer Cells.

    Wu Z, Bonneil E, Belford M, Boeser C, Ruiz Cuevas MV, Lemieux S, Dunyach JJ, Thibault P
    Anal Chem 2022-09-06 ;94( 35 ):12086-12094.

  • septembre 5, 2022

    From a Cone Snail Toxin to a Competitive MC4R Antagonist.

    Reynaud S, Laurin SA, Ciolek J, Barbe P, Van Baelen AC, Susset M, Blondel F, Ghazarian M, Boeri J, Vanden Driessche M, Upert G, Mourier G, Kessler P, Konnert L, Beroud R, Keck M, Servent D, Bouvier M, Gilles N
    J Med Chem 2022-09-05 ;.

  • septembre 1, 2022

    Structural keys unlock RAS-MAPK cellular signalling pathway.

    Lavoie H, Therrien M
    Nature 2022-09-01 ;609( 7926 ):248-249.

  • septembre 1, 2022

    DNA barcoded competitive clone-initiating cell analysis reveals novel features of metastatic growth in a cancer xenograft model.

    Aalam SMM, Tang X, Song J, Ray U, Russell SJ, Weroha SJ, Bakkum-Gamez J, Shridhar V, Sherman ME, Eaves CJ, Knapp D, Kalari KR, Kannan N
    NAR Cancer 2022-09-01 ;4( 3 ):zcac022.

  • septembre 1, 2022

    Michaelis-Menten Quantification of Ligand Signaling Bias Applied to the Promiscuous Vasopressin V2 Receptor.

    Heydenreich FM, Plouffe B, Rizk A, Milić D, Zhou J, Breton B, Le Gouill C, Inoue A, Bouvier M, Veprintsev DB
    Mol Pharmacol 2022-09-01 ;102( 3 ):139-149.

Load more publications